Thursday, 01 December 2016 07:44

Circulation Of Two Falsified Quinine Sulphate

Rate this item
(0 votes)

The National Agency for Food and Drug Administration and Control (NAFDAC) has been notified of the circulation of two confirmed falsified Quinine Sulphate 300mg tablet versions in Cameroon and the Democratic Republic of Congo.  The products have been found to contain zero active pharmaceutical ingredients.

Quinine Sulphate is an anti-malaria drug used for the treatment of Plasmodium falciparum Malaria. These falsified products were first discovered by a local NGO on failing field screening. They were submitted to a WHO pre-qualified Quality Assurance Laboratory and subsequent analysis from the laboratory showed neither of the products contained any of the stated active ingredients.

The details of the falsified products are;

Falsified version 1 Falsified version 2

Product Name: Quinine Sulphate 300mg

Manufacturer: Novadina Pharmaceutical Ltd,  

                            London, United Kingdom

Number of tablets per container: 1000

Batch Number: 10H05

Date of Manufacture:  09/2014

Expiry date: 09/2018

Product Name: Quinine Sulphate 300mg

Manufacturer: CAD Pharm, India

Number of tablets per container: 100

Batch Number: F4387

Date of Manufacture:  12/14

Expiry date: 11/18

NAFDAC implores healthcare providers to ensure vigilance to prevent the administration of the confirmed falsified products to unsuspected patients.

Healthcare providers should notify the nearest NAFDAC office of any information concerning the distribution, sale and use of the falsified Quinine Sulphate 300mg tablet.

 

 

NAFDAC...........Safeguarding the health of the Nation!!!

Read 2376 times Last modified on Thursday, 01 December 2016 08:10

CORPORATE LINKS